DGCI gives nod for Phase 3 trials of intranasal vaccine
RNS: The subject expert committee (SEC) of Drugs controller General of India (DCGI) has recommended that Hyderabad-based Bharat Biotech can …
DGCI gives nod for Phase 3 trials of intranasal vaccine Read More